Home › Neuroendocrine Tumors › Pennsylvania › Philadelphia

Pag-aaral pangklinika para sa Neuroendocrine Tumors sa Philadelphia, PA

Isang pag-aaral para sa Neuroendocrine Tumors ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Philadelphia. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Nagre-recruitPhase 2/3

University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06943755

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Nagre-recruitPhase 1

The Children's Hospital of Philadelphia (CHOP), Philadelphia

24 Months – 18 Years · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06441331

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Nagre-recruitPhase 3

Hospital of the University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07087054

Project: Every Child for Younger Patients With Cancer

Nagre-recruitObservasyonal na pag-aaral

Drexel University School of Medicine, Philadelphia
Children's Hospital of Philadelphia, Philadelphia
Saint Christopher's Hospital for Children, Philadelphia
at 1 pa

Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

Nagre-recruitPhase 1/2

Crinetics Study Site, Philadelphia
Crinetics Study Site, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT07129252

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

Nagre-recruitPhase 2

Fox Chase Cancer Center, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT05263050

CapTemY90 for Grade 2/3 NET Liver Metastases

Nagre-recruitPhase 2

University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT04339036

Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Nagre-recruitPhase 1/2

University of Pennsylvania, Philadelphia

Edad 20 hanggang 99 · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT02174549

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

Nagre-recruitPhase 1/2

University of Pennsylvania, Philadelphia

Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ene 29, 2026 · NCT06055439

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Nagre-recruitPhase 4

Albert Einstein Healthcare Network, Philadelphia

Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Ene 22, 2026 · NCT04373564

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Philadelphia

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Neuroendocrine Tumors sa ibang lungsod

Iba pang pag-aaral sa Philadelphia

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.